Click for best price
Peptide Receptor Radionuclide Therapy PRRT Market Size, Share 2022
Peptide receptor radionuclide therapy (PRRT) is a type of molecular therapy, also known as radioisotope therapy that is used for treating neuroendocrine tumors.?
This report contains market size and forecasts of Peptide Receptor Radionuclide Therapy (PRRT) in Global, including the following market information:
Global Peptide Receptor Radionuclide Therapy (PRRT) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Peptide Receptor Radionuclide Therapy (PRRT) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gastroenteropancreatic Neuroendocrine Tumor Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peptide Receptor Radionuclide Therapy (PRRT) include Novartis, ITM Solucin, National Institutes of Health and Australasian Gastro-Intestinal Trials Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Peptide Receptor Radionuclide Therapy (PRRT) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide Receptor Radionuclide Therapy (PRRT) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Peptide Receptor Radionuclide Therapy (PRRT) Market Segment Percentages, by Type, 2021 (%)
Gastroenteropancreatic Neuroendocrine Tumor
Foregut Neuroendocrine Tumor
Midgut Neuroendocrine Tumor
Hindgut Neuroendocrine Tumor
Global Peptide Receptor Radionuclide Therapy (PRRT) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Peptide Receptor Radionuclide Therapy (PRRT) Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Peptide Receptor Radionuclide Therapy (PRRT) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Peptide Receptor Radionuclide Therapy (PRRT) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide Receptor Radionuclide Therapy (PRRT) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Peptide Receptor Radionuclide Therapy (PRRT) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
ITM Solucin
National Institutes of Health
Australasian Gastro-Intestinal Trials Group
| Report Attributes |
Report Details |
| Report Title |
Peptide Receptor Radionuclide Therapy (PRRT) Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peptide Receptor Radionuclide Therapy (PRRT) Overall Market Size
2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size: 2021 VS 2028
2.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peptide Receptor Radionuclide Therapy (PRRT) Players in Global Market
3.2 Top Global Peptide Receptor Radionuclide Therapy (PRRT) Companies Ranked by Revenue
3.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Companies
3.4 Top 3 and Top 5 Peptide Receptor Radionuclide Therapy (PRRT) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Peptide Receptor Radionuclide Therapy (PRRT) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peptide Receptor Radionuclide Therapy (PRRT) Players in Global Market
3.6.1 List of Global Tier 1 Peptide Receptor Radionuclide Therapy (PRRT) Companies
3.6.2 List of Global Tier 2 and Tier 3 Peptide Receptor Radionuclide Therapy (PRRT) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Markets, 2021 & 2028
4.1.2 Gastroenteropancreatic Neuroendocrine Tumor
4.1.3 Foregut Neuroendocrine Tumor
4.1.4 Midgut Neuroendocrine Tumor
4.1.5 Hindgut Neuroendocrine Tumor
4.2 By Type - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue & Forecasts
4.2.1 By Type - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2022
4.2.2 By Type - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2023-2028
4.2.3 By Type - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue & Forecasts
5.2.1 By Application - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2022
5.2.2 By Application - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2023-2028
5.2.3 By Application - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2021 & 2028
6.2 By Region - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue & Forecasts
6.2.1 By Region - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2022
6.2.2 By Region - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2023-2028
6.2.3 By Region - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2028
6.3.2 US Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.3.3 Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.3.4 Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2028
6.4.2 Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.4.3 France Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.4.4 U.K. Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.4.5 Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.4.6 Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.4.7 Nordic Countries Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.4.8 Benelux Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2028
6.5.2 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.5.3 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.5.4 South Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.5.5 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.5.6 India Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2028
6.6.2 Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.6.3 Argentina Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2028
6.7.2 Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.7.3 Israel Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.7.4 Saudi Arabia Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.7.5 UAE Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
7 Players Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Major Product Offerings
7.1.4 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue in Global Market (2017-2022)
7.1.5 Novartis Key News
7.2 ITM Solucin
7.2.1 ITM Solucin Corporate Summary
7.2.2 ITM Solucin Business Overview
7.2.3 ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Major Product Offerings
7.2.4 ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Revenue in Global Market (2017-2022)
7.2.5 ITM Solucin Key News
7.3 National Institutes of Health
7.3.1 National Institutes of Health Corporate Summary
7.3.2 National Institutes of Health Business Overview
7.3.3 National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Major Product Offerings
7.3.4 National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Revenue in Global Market (2017-2022)
7.3.5 National Institutes of Health Key News
7.4 Australasian Gastro-Intestinal Trials Group
7.4.1 Australasian Gastro-Intestinal Trials Group Corporate Summary
7.4.2 Australasian Gastro-Intestinal Trials Group Business Overview
7.4.3 Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Major Product Offerings
7.4.4 Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Revenue in Global Market (2017-2022)
7.4.5 Australasian Gastro-Intestinal Trials Group Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Peptide Receptor Radionuclide Therapy (PRRT) Market Opportunities & Trends in Global Market
Table 2. Peptide Receptor Radionuclide Therapy (PRRT) Market Drivers in Global Market
Table 3. Peptide Receptor Radionuclide Therapy (PRRT) Market Restraints in Global Market
Table 4. Key Players of Peptide Receptor Radionuclide Therapy (PRRT) in Global Market
Table 5. Top Peptide Receptor Radionuclide Therapy (PRRT) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Peptide Receptor Radionuclide Therapy (PRRT) Product Type
Table 9. List of Global Tier 1 Peptide Receptor Radionuclide Therapy (PRRT) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptide Receptor Radionuclide Therapy (PRRT) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Peptide Receptor Radionuclide Therapy (PRRT) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Peptide Receptor Radionuclide Therapy (PRRT) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Peptide Receptor Radionuclide Therapy (PRRT) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Peptide Receptor Radionuclide Therapy (PRRT) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product Offerings
Table 32. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue (US$, Mn), (2017-2022)
Table 33. ITM Solucin Corporate Summary
Table 34. ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Product Offerings
Table 35. ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Revenue (US$, Mn), (2017-2022)
Table 36. National Institutes of Health Corporate Summary
Table 37. National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Product Offerings
Table 38. National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Revenue (US$, Mn), (2017-2022)
Table 39. Australasian Gastro-Intestinal Trials Group Corporate Summary
Table 40. Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Product Offerings
Table 41. Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Peptide Receptor Radionuclide Therapy (PRRT) Segment by Type in 2021
Figure 2. Peptide Receptor Radionuclide Therapy (PRRT) Segment by Application in 2021
Figure 3. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Peptide Receptor Radionuclide Therapy (PRRT) Revenue in 2021
Figure 8. By Type - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share, 2017-2028
Figure 12. US Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share, 2017-2028
Figure 16. Germany Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 17. France Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share, 2017-2028
Figure 24. China Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 28. India Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share, 2017-2028
Figure 30. Brazil Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share, 2017-2028
Figure 33. Turkey Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Peptide Receptor Radionuclide Therapy (PRRT) Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
